Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 7—July 2005

Bordetella petrii Clinical Isolate

Norman K. Fry*Comments to Author , John Duncan*, Henry Malnick*, Marina Warner*, Andrew J. Smith†, Margaret S. Jackson†, and Ashraf Ayoub†
Author affiliations: *Health Protection Agency, London, United Kingdom; †Glasgow Dental Hospital and School, Glasgow, United Kingdom

Main Article


Results of antimicrobial drug–susceptibility testing for strain GDH030510

Antimicrobial agent MIC (μg/mL)
Penicillin >32
Ampicillin >256
Piperacillin/tazobactam 2
Ceftriaxone >32
Cefotaxime >32
Ceftazidime 32
Imipenem >32
Meropenem >32
Ertapenem >32
Amikacin >256
Gentamicin 4
Tobramycin 16
Ciprofloxacin >32
Erythromycin 128
Azithromycin 4
Clarithromycin 64
Clindamycin >256
Chloramphenicol >256
Cotrimoxazole 8
Rifampin >32
Tetracycline >256

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.